Kathryn Swoboda is a Neurology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 259 publications with 18,484 citations (h-index 71); ClinicalTrials.gov lists 8 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Boston, MA 021142621
Telephone
617-726-5732Registry record last updated 11 Mar 2015.
Clinical trials
- Prospective Evaluation of Infants With Spinal Muscular Atrophy:
Sponsor: Massachusetts General Hospital
- Study of Kuvan Treatment in Adults With GTPCH Deficiency
Sponsor: University of Utah
- Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
Sponsor: University of Utah
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Gene Therapies, Inc. (fka AveXis, Inc.)Program year20231 payment
- Novartis Gene Therapies, Inc. (fka AveXis, Inc.)Program year202212 payments
- Biogen, Inc.Program year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2015–2019 per NIH RePORTER. The latest:
- Neural and non-neural contributions to phenotype in human SMA type 1
Massachusetts General Hospital
FY2019$252,750R21NS108015 - Neural and non-neural contributions to phenotype in human SMA type 1
Massachusetts General Hospital
FY2018$210,625R21NS108015 - Newborn screening for identification & prospective followup of infants with SMA
Massachusetts General Hospital
FY2015$862,570R01HD069045
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”